4Filed Sep 2, 8:00 PM ET

Labcorp (LH) EVP Vaughn T. Bryan Receives Award of 1,500 RSUs

$LH · LABCORP HOLDINGS INC.

Research Summary

AI-generated summary of this SEC filing

Updated

Labcorp (LH) EVP Vaughn T. Bryan Receives Award of 1,500 RSUs

What Happened

  • Vaughn T. Bryan, EVP and President, Diagnostics at Labcorp Holdings Inc. (LH), was granted 1,500 restricted stock units (RSUs) on 2026-09-01. The grant is reported as a derivative award with an acquisition price of $0.00 (no cash paid). Each RSU represents the contingent right to receive one share of Labcorp common stock.

Key Details

  • Transaction date: 2026-09-01; Form 4 filed: 2026-09-03 (timely).
  • Grant: 1,500 RSUs; acquisition price reported as $0.00.
  • Shares/units held after the transaction: 1,500 RSUs (aggregate, per filing).
  • Vesting: RSUs vest in three equal annual installments beginning September 1, 2027 (see footnote).
  • Transaction type: Award/Grant (derivative). No 10b5-1, tax withholding, or sales reported in this filing.

Context

  • RSU grants are a form of compensation rather than an open-market purchase or sale; they vest over time and convert to shares only if vesting conditions are met. Such grants are common for executives and do not by themselves signal a buy/sell decision in the market.